Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
37
NCT05486195
A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect
Phase: Phase 1
Role: Collaborator
Start: Mar 14, 2019
Completion: Mar 11, 2020
NCT05212116
A Study of SDI-118 in Participants in Remission From Depression
Role: Lead Sponsor
Start: Sep 16, 2021
Completion: Mar 11, 2022
NCT05199142
A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SDI-118 in Elderly Male and Female Study Participants With Cognitive Decline
Start: Sep 23, 2021